[18F]-Fludarabine PET/MRI in Primary Central Nervous System Lymphoma

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 18, 2023

Primary Completion Date

December 5, 2024

Study Completion Date

December 5, 2024

Conditions

Primary Central Nervous System Lymphoma

Interventions

DRUG

PET-MRI

\[18F\]-Fludarabine imaging in the diagnostic workup of primary central nervous system lymphomas: a PET-MRI pilot study

Trial Locations (1)

Hôpital Pitié Salpêtrière, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05390814 - [18F]-Fludarabine PET/MRI in Primary Central Nervous System Lymphoma | Biotech Hunter | Biotech Hunter